The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes following involved field radiotherapy (IFRT) with or without rituximab in patients (Pts) with limited-stage low-grade non-Hodgkin lymphoma (NHL) staged with CT versus PET.
J. N. Lukens
No relevant relationships to disclose
S. Nasta
No relevant relationships to disclose
E. Glatstein
No relevant relationships to disclose
J. P. Plastaras
No relevant relationships to disclose